LHRH analogues as primary treatment for urinary retention in patients with prostatic carcinoma.
Thirty-one patients with retention of urine and carcinoma of the prostate were treated with LHRH analogues as primary therapy rather than prostatectomy; 21 patients voided without the need for surgical intervention. Patients presenting in acute retention of urine voided more readily than those presenting in chronic retention, with only 20% requiring surgery. This approach to treatment is safe, efficacious and cost effective.
Department of Urology, St George's Hospital, London.
S J
SJ
Hampson
J H
JH
Davies
C R
CR
Charig
R J
RJ
Shearer
D000208:Acute Disease; D000368:Aged; D002908:Chronic Disease; D017273:Goserelin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011467:Prostate / Q000473:pathology; D011471:Prostatic Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D016055:Urinary Retention / Q000188:drug therapy* / Q000209:etiology; D014554:Urination
D017273:Goserelin